Literature DB >> 17380072

[The age-specific seroprevalence of hepatitis A virus antibody in Korea].

Young Bong Song1, Joon Hyoek Lee, Moon Seok Choi, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Yoon-Ho Choi, Hee Jung Sohn, Kyung Han Lee, Jong Chul Rhee.   

Abstract

BACKGROUNDS AND AIMS: The epidemiology of hepatitis A is associated with socioeconomic and hygiene status. Recently, the prevalence of hepatitis A in young adults has been steadily increasing in Korea. This study is to investigate the age-specific seroprevalence of hepatitis A virus in Korea.
METHODS: Stored sera from 250 healthy adult subjects who visited the health promotion center in Samsung Medical Center between July and August 2006 were tested for IgG hepatitis A virus antibody (anti-HAV).
RESULTS: The prevalence of anti-HAV was 2%, 72%, 92%, 94%, 100% in 20's, 30's, 40's, 50's, and 60's, respectively. The prevalence of anti-HAV was significantly lower in subjects below age 40 compared to those above 40 (37.0% vs. 95.3%, p<0.001). The seroprevalence was higher in area outside of Seoul compared to those living in Seoul in age group below 40 (25.6% vs. 55.6%, p=0.01). In Seoul area, the prevalence was significantly lower in Kangnam-Gu, Seocho-Gu, and Songpa-Gu district compared to the other areas of Seoul in the age group below 40 (20.0% vs. 42.1%, p<0.05).
CONCLUSION: The seroprevalence of hepatitis A virus antibody in Korean population below 40 is quite low and immunity to hepatitis A virus in those subjects can be a public health issue. In view of changing seroepidemiology, a policy for hepatitis A vaccination in population below 40 might be warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380072

Source DB:  PubMed          Journal:  Korean J Hepatol        ISSN: 1738-222X


  13 in total

1.  A nationwide seroprevalence of total antibody to hepatitis A virus from 2005 to 2009: age and area-adjusted prevalence rates.

Authors:  Donghun Lee; Moran Ki; Anna Lee; Kyoung Ryul Lee; Hee Bong Park; Chang Sub Kim; Bo Young Yoon; Jong Hyun Kim; Young Sok Lee; Sook Hyang Jeong
Journal:  Korean J Hepatol       Date:  2011-03

2.  KASL Clinical Practice Guidelines: Management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2012-06-26

3.  Seroprevalence of hepatitis a and associated socioeconomic factors in young healthy korean adults.

Authors:  Goh Eun Chung; Jeong Yoon Yim; Donghee Kim; Seon Hee Lim; Min Jung Park; Young Sun Kim; Sun Young Yang; Jong In Yang; Sang-Heon Cho
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

4.  Vaccination rate and seroepidemiology of hepatitis a in chronic-hepatitis-B-infected individuals in the korean army.

Authors:  Dong Hyuk Shin; Sang Kuk Han; Pil Cho Choi; Seong Woo Lim; Kyung Mook Kim; Dong Hyun Sinn
Journal:  Gut Liver       Date:  2010-06-16       Impact factor: 4.519

5.  Epidemiological changes in hepatitis A in Korea: increasing age and its effect on clinical outcomes.

Authors:  J J Shim; S O Chin; C K Lee; J Y Jang; B H Kim
Journal:  Epidemiol Infect       Date:  2012-02-16       Impact factor: 4.434

6.  Seroepidemiology of hepatitis A in Korea: changes over the past 30 years.

Authors:  Hyunju Lee; Hye Kyung Cho; Jong-Hyun Kim; Kyung-Hyo Kim
Journal:  J Korean Med Sci       Date:  2011-05-18       Impact factor: 2.153

7.  Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea.

Authors:  Sang Ho Lee; Hyoung Su Kim; Kwon Oh Park; Jong Won Park; Seung Yeon Chun; Seung Jin Lim; Hyun Jung Cho; Sung Jun Kim; Hye Won Park; Han Kook Moon; Woon Geon Shin; Kyung Ho Kim; Myoung Kuk Jang; Jin Heon Lee; Hak Yang Kim
Journal:  Korean J Hepatol       Date:  2010-12

8.  Pattern of hepatitis a incidence according to area characteristics using national health insurance data.

Authors:  Joo Youn Seo; Jae Hee Seo; Myoung Hee Kim; Moran Ki; Hee Suk Park; Bo Youl Choi
Journal:  J Prev Med Public Health       Date:  2012-05-31

9.  Factors related to completed status and seropositivity of hepatitis a immunization among children aged 1-3 years and 6-8 years in South Korea.

Authors:  Jee-Young Hong; Mo Ran Ki; Hye-Jung Hwang; Delacroix Sinny; Young-Joon Park; Geun-Ryang Bae; Moo-Sik Lee
Journal:  Osong Public Health Res Perspect       Date:  2013-04

10.  Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea.

Authors:  Sung Jun Chung; Tae Yeob Kim; Sun Min Kim; Min Roh; Mi Yeon Yu; Jung Hoon Lee; ChangKyo Oh; Eun Young Lee; Seung Lee; Yong Cheol Jeon; Kyo-Sang Yoo; Joo Hyun Sohn
Journal:  Clin Mol Hepatol       Date:  2014-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.